Skip to main content

Advertisement

Fig. 4 | BMC Cancer

Fig. 4

From: FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma

Fig. 4

The features of FDG PET/CT and prognosis. (a, b, c) A case with ovarian recurrence and a max SUVmax of 3.2. (d, e, f) A case with a primary tumor and a max SUVmax of 5.2. (g, h, i) A case with lung metastasis and a max SUVmax of 9.4. (j, k, l) A case with submandibular lymph node metastasis and a max SUVmax of 11.0. (m, n, o) A case with a primary tumor and a max SUVmax of 14.3. a d g j m: CT imaging. b e h k n: PET images. c f i l o: fusion images. mo=month. CD=cancer death

Back to article page